Early Salivary miRNA Expression in Extreme Low Gestational Age Newborns.
BPD
chronic lung disease
miRNA
saliva sample
tracheal aspirate
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
30 Mar 2022
30 Mar 2022
Historique:
received:
18
02
2022
revised:
07
03
2022
accepted:
23
03
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
24
4
2022
Statut:
epublish
Résumé
Background: MicroRNAs (miRNA) are small non-coding RNAs that regulate gene expression playing a key role in organogenesis. MiRNAs are studied in tracheal aspirates (TA) of preterm infants. However; this is difficult to obtain in infants who are not intubated. This study examines early salivary miRNA expression as non-invasive early biomarkers in extremely low gestational age newborns (ELGANs). Methods: Saliva was collected using DNA-genotek swabs, miRNAs were analyzed using RNA seq and RT PCR arrays. Salivary miRNA expression was compared to TA using RNA seq at 3 days of age, and longitudinal changes at 28 days of age were analyzed using RT PCR arrays in ELGANs. Results: Approximately 822 ng of RNA was extracted from saliva of 7 ELGANs; Of the 757 miRNAs isolated, 161 miRNAs had significant correlation in saliva and TA at 3 days of age (r = 0.97). Longitudinal miRNA analysis showed 29 miRNAs downregulated and 394 miRNAs upregulated at 28 days compared to 3 days of age (adjusted p < 0.1). Bioinformatic analysis (Ingenuity Pathway Analysis) of differentially expressed miRNAs identified organismal injury and abnormalities and cellular development as the top physiological system development and cellular function. Conclusion: Salivary miRNA expression are source for early biomarkers of underlying pathophysiology in ELGANs.
Identifiants
pubmed: 35454997
pii: life12040506
doi: 10.3390/life12040506
pmc: PMC9029747
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Pennsylvania Department of Health CURE fund
ID : n/a
Organisme : Children's Miracle Network
ID : n/a
Références
Cancer Manag Res. 2020 Apr 07;12:2471-2479
pubmed: 32308483
Front Pediatr. 2016 Mar 31;4:33
pubmed: 27065351
Semin Perinatol. 2015 Dec;39(8):584-91
pubmed: 26471063
Stem Cell Res Ther. 2021 Jan 18;12(1):64
pubmed: 33461605
Eur Med J (Chelmsf). 2019 Mar;4(1):20-29
pubmed: 31372499
Biomedicines. 2021 Mar 05;9(3):
pubmed: 33807742
Eur Respir J. 2021 Oct 1;58(3):
pubmed: 32457196
Semin Perinatol. 2006 Aug;30(4):179-84
pubmed: 16860157
Cancer Med. 2020 Aug;9(16):5989-5998
pubmed: 32618144
Exp Biol Med (Maywood). 2017 Mar;242(5):459-472
pubmed: 27903834
World J Gastroenterol. 2016 Jun 21;22(23):5364-73
pubmed: 27340352
Theranostics. 2019 Sep 21;9(23):6901-6919
pubmed: 31660076
J Perinatol. 2014 Mar;34(3):169-73
pubmed: 24406743
J Perinatol. 2021 Mar;41(3):551-561
pubmed: 33177681
Eur J Dent Educ. 2008 Feb;12 Suppl 1:22-9
pubmed: 18289265
J Exp Clin Cancer Res. 2020 Jan 2;39(1):4
pubmed: 31898515
Clin Transl Med. 2020 Oct;10(6):e197
pubmed: 33135344
Methods Mol Biol. 2012;822:261-72
pubmed: 22144205
Biomed Pharmacother. 2020 Jan;121:109603
pubmed: 31707339
J Cancer. 2020 Jun 6;11(16):4801-4809
pubmed: 32626527
Trends Biochem Sci. 2007 Apr;32(4):189-97
pubmed: 17350266
Elife. 2019 Sep 03;8:
pubmed: 31478836
Bioinformatics. 2003 Feb 12;19(3):368-75
pubmed: 12584122
Semin Liver Dis. 2015 Feb;35(1):3-11
pubmed: 25632930
J Clin Med. 2020 Feb 08;9(2):
pubmed: 32046271
Clin Biochem. 2011 May;44(7):467-8
pubmed: 22145169
Cells. 2021 Sep 26;10(10):
pubmed: 34685526
J Cell Biochem. 2019 Jun;120(6):9369-9380
pubmed: 30802330
Br J Cancer. 2015 Jan 20;112(2):365-74
pubmed: 25422913
Biol Res Nurs. 2020 Jan;22(1):13-23
pubmed: 31833409
Oncotarget. 2015 Sep 8;6(26):22959-69
pubmed: 26008976
J Am Acad Child Adolesc Psychiatry. 2020 Feb;59(2):296-308
pubmed: 30926572
Bioinformatics. 2010 Jan 1;26(1):136-8
pubmed: 19855105
Algorithms Mol Biol. 2016 Sep 15;11:24
pubmed: 27651826
Genet Mol Res. 2013 Oct 30;12(4):5195-206
pubmed: 24301780
JCI Insight. 2018 Mar 8;3(5):
pubmed: 29515035